Transglutaminase 2-Mediated p53 Depletion Promotes Angiogenesis by Increasing HIF-1α-p300 Binding in Renal Cell Carcinoma

A Precision Strategy to Cure Renal Cell Carcinoma by Targeting Transglutaminase 2

(2020) Soo-Youl Kim et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Transglutaminase 2 Promotes Autophagy by LC3 Induction Through p53 Depletion in Cancer Cell

(2018) Joon Hee Kang et al.   Biomolecules & Therapeutics

Mapping the minimum domain of the fibronectin binding site on transglutaminase 2 (TG2) and its importance in mediating signaling, adhesion, and migration in TG2-expressing cells

(2018) Maria Felicia Soluri et al.   FASEB JOURNAL

Renal Cell Carcinoma Is Abrogated by p53 Stabilization through Transglutaminase 2 Inhibition

(2018) Seon-Hyeong Lee et al.   Cancers

A class of extracellular vesicles from breast cancer cells activates VEGF receptors and tumour angiogenesis

(2017) Qiyu Feng et al.   Nature Communications

Dissecting the interaction between transglutaminase 2 and fibronectin

(2016) Inês Cardoso et al.   AMINO ACIDS

Discovery of a novel target for renal cell carcinoma: transglutaminase 2

(2016) J H Kang et al.   Cell Death & Disease

Renal cell carcinoma escapes death by p53 depletion through transglutaminase 2-chaperoned autophagy

(2016) J H Kang et al.   Cell Death & Disease

Structural Basis for Antigen Recognition by Transglutaminase 2-specific Autoantibodies in Celiac Disease

(2015) Xi Chen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The p53 family and the hypoxia-inducible factors (HIFs): determinants of cancer progression

(2015) Ivano Amelio et al.   TRENDS IN BIOCHEMICAL SCIENCES

Transglutaminase 2 inhibitor abrogates renal cell carcinoma in xenograft models

(2014) Bo Mi Ku et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma

(2014) Selcuk Erdem et al.   WORLD JOURNAL OF UROLOGY

Potential New Mechanisms of Placental Damage in Celiac Disease: Anti-Transglutaminase Antibodies Impair Human Endometrial Angiogenesis1

(2013) Nicoletta Di Simone et al.   BIOLOGY OF REPRODUCTION

Transglutaminase 2 inhibition found to induce p53 mediated apoptosis in renal cell carcinoma

(2013) Bo Mi Ku et al.   FASEB JOURNAL

Transglutaminase-2: a new endostatin partner in the extracellular matrix of endothelial cells

(2010) Clément Faye et al.   BIOCHEMICAL JOURNAL

The First Draft of the Endostatin Interaction Network

(2009) Clément Faye et al.   JOURNAL OF BIOLOGICAL CHEMISTRY